Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach

To date, there are no serum biomarkers available for the prediction of recurrent nasopharyngeal carcinoma (rNPC). The diagnosis of rNPC mostly depends on imaging and biopsy of diseased tissue; however, both of these methods work mostly if the target tumor is at an advanced stage. Therefore, the iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Huiling, Zhu, Xiaodong, Li, Ling, Liang, Zhongguo, Li, Xiaoyu, Pan, Xinbin, Zeng, Fanyan, Qu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593497/
https://www.ncbi.nlm.nih.gov/pubmed/28849027
http://dx.doi.org/10.3892/ijmm.2017.3094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593497/
https://www.ncbi.nlm.nih.gov/pubmed/28849027
http://dx.doi.org/10.3892/ijmm.2017.3094

Ejemplares similares